TELA Bio (TELA) Revenue (2018 - 2026)

TELA Bio has reported Revenue for 9 years, with the latest figure at $19.3 million in Q2 2026.

• On a quarterly basis, Revenue fell 4.49% year-over-year to $19.3 million in Q2 2026; TTM through Jun 2026 was $79.9 million, a 6.09% increase from a year earlier, with the FY2025 full-year figure at $80.3 million, up 15.84% from the prior year.
• Revenue was $19.3 million for Q2 2026 at TELA Bio, up from $19.1 million in the prior quarter.
• The five-year high for Revenue was $20.9 million in Q4 2025, with the low at $8.2 million in Q1 2022.
• Average Revenue over 5 years is $16.0 million, with a median of $16.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Revenue soared 46.26% in 2023, then fell 4.49% in 2026.
• Over 5 years, Revenue stood at $11.6 million in 2022, then surged by 46.26% to $17.0 million in 2023, then advanced by 3.83% to $17.6 million in 2024, then gained by 18.24% to $20.9 million in 2025, then decreased by 7.56% to $19.3 million in 2026.
• The last three Revenue figures came in at $19.3 million (Q2 2026), $19.1 million (Q1 2026), and $20.9 million (Q4 2025), per Business Quant data.